The Czech National Health Care Information System (NH-IS) and its strategy in building population-based reporting

Similar documents
Quantitative immunochemical tests: evidence on accuracy and implementation considerations in the Czech MUDr.. Petr Kocna, CSc.

Best practices in collecting and processing data in CRC screening and after it

CRC screening in the Era of informatics: can data-based knowledge enhance coverage?

Monitoring of equity in access to CRC screening and CRC care: two sides of the same coin

Clinical CRC registries of the Czech Society for Oncology

Practical challenges in establishing and running the Czech national colorectal cancer screening programme

4th EUROPEAN COLORECTAL CANCER DAYS

Additional Information to the Press Release

COLORECTAL CANCER: A CHALLENGE FOR HEALTHY LIFESTYLE, SCREENING AND PROPER CARE

Efficacy, effectiveness, quality: sources of data

Can epidemiological data contribute to improvement in cancer care?

Measuring performance and quality indicators of CRC screening

Winnable Battles: Cancer in Colorado. Joni Reynolds, RN-CNS, MSN Director of Public Health Programs

NCI-designated Cancer Centers & Colorectal Cancer Screening

Cancer Control Plan & Cancer Registry in Korea

Author Block M. Fisch, J. W. Lee, J. Manola, L. Wagner, V. Chang, P. Gilman, K. Lear, L. Baez, C. Cleeland University of Texas M.D. Anderson Cancer Ce

Lessons learnt from cancer screening programmes as an example for establishing the Czech National Coordination Centre

Breast Cancer Services in Germany

Georgia Cancer Quality Information Exchange

CRC screening from the viewpoint of its clients and patients results of survey

TURKEY. Prof.Dr.F.Nur BARAN AKSAKAL Prof.Dr. Serhat ÜNAL. 6th Mena Influenza Stakeholders Meeting. Organized by Fondation Mérieux

Primary care at the forefront of colorectal cancer screening

Czech CRC screening program at the point of switch to the population based design

SUSTAINING ACCESS TO HIGH QUALITY RADIOTHERAPY CARE: A LMIC PERSPECTIVE

FOLLICULAR LYMPHOMA: US vs. Europe: different approach on first relapse setting?

How to improve the reliability of Single Arm Trials

Member-centered cancer care In Georgia

Colonoscopy overuse in colorectal cancer screening in Argentina. Ignacio Ricci

COMMISSION OF THE EUROPEAN COMMUNITIES

Community Benefit Strategic Implementation Plan. Better together.

Predictors of Palliative Therapy Receipt in Stage IV Colorectal Cancer

CANCER REGISTRY REPORT

INTERACTION WITH SCREENEES AND PATIENT ORGANIZATIONS

Center to Advance Palliative Care:

Practice Based Research at UC San Diego Family Medicine

Interventions to Improve Follow-up of Positive Results on Fecal Blood Tests

Cancer screening: Breast

WHAT SHOULD WE DO WITH TUMOUR BUDDING IN EARLY COLORECTAL CANCER?

Palliative Care & Private Health Insurance

Thin Film PV Technologies CIGS PV Technology

p Ontario tr Ontario Ontario Palliative Care Network Action Plan 1: I'.,.. -~ Action Areas, Actions and Timelines

Michael A. Preston, Ph.D., M.P.H. University of Arkansas for Medical

Comprehensive Cancer Control Technical Assistance Training and Communication Plan. PI: Mandi Pratt-Chapman, MA. Cooperative Agreement #1U38DP

HPV vaccination in the Czech Republic

Enabling pragmatic clinical trials embedded in health care systems

GSJ Geochemical Reference Samples. Igneous Rock. Sedimentary Rock. For Instrumental analysis. Reference value for environmental analysis -1

Outcome from the Joint Action on Cancer Control CanCon

Country report Serbia April 2017

Together Until the End

Commissioning Cancer Services. Andy McMeeking RCGP/NCIN Primary Care Workshop, 13 th February 2013

DIGNITY IN DEMENTIA. G7 dementia legacy event Japan 6 th November 2014

Management Of Patients With Metastatic Colorectal Cancer in Lebanese Hospitals and Associated Direct Cost: A Multicenter Cohort Study

PROPOSED WORK PROGRAMME FOR THE CLEARING-HOUSE MECHANISM IN SUPPORT OF THE STRATEGIC PLAN FOR BIODIVERSITY Note by the Executive Secretary

Impressions of a New NCI Director: Big Data

Cancer screening information in one complete report in Alberta Netcare

Big Data & Predictive Analytics Case Studies: Applying data science to human data Big-Data.AI Summit

The TNM classification is a worldwide benchmark for reporting the

The Cost of Waiting: Implications of the Timing of Palliative Care Consultation among a Cohort of Decedents at a Comprehensive Cancer Center

Adjuvant Radiotherapy for completely resected NSCLC

Measuring Functional Change in Outpatient Therapy Claims-Based Data Collection Reqs. for Outpatient Therapy Services

HBM surveillance program for PCBs and heavy metals in the Czech Republic. Milena Černá, A. Krsková

ASCO Quality Oncology Practice Initiative (QOPI): Implications For A Rapid Learning System For Cancer

DCP Networks

NHS BLOOD AND TRANSPLANT LIVER ADVISORY GROUP WAITING TIMES AND DEATHS ON THE LIST BY BLOOD GROUP SUMMARY

2017 CANCER ANNUAL REPORT

Using Analytics for Value-Based Care

The Current Status of Immune Checkpoint Inhibitors: Arvin Yang, MD PhD Oncology Global Clinical Research Bristol-Myers Squibb

Quantification of the effect of mammographic screening on fatal breast cancers: The Florence Programme

PLENARY SESSION 1: CLINICAL TRIAL DESIGN IN AN ERA OF HORIZONTAL DRUG DEVELOPMENT Industry Perspective

Use of Single-Arm Cohorts/Trials to Demonstrate Clinical Benefit for Breakthrough Therapies. Eric H. Rubin, MD Merck Research Laboratories

WAGENINGEN EVALUATING PROGRAMS FOR ANALYTICAL LABORATORIES. Certificate of Analysis. International Plant-Analytical Exchange REFERENCE MATERIAL

2015 Patient Outcomes Report

Title: Breast Screen Reader Assessment Strategy (BREAST): UK Collaboration

Enhancing Quality of Life for Cancer Survivors in South Dakota. Outcomes from the South Dakota Cancer Survivorship Program

REPORT FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT, THE COUNCIL, THE EUROPEAN ECONOMIC AND SOCIAL COMMITTEE AND THE COMMITTEE OF THE REGIONS

Techniques to Improve Resectability of Colorectal Liver Metastases Ching-Wei D. Tzeng, M.D.

Performance of Colorectal cancer screening in the European Union Member States Data from the second European screening report

Collaborative Project of the 7th Framework Programme. WP6: Tools for bio-researchers and clinicians

Efficacy of Bendamustine and rituximab in a real-world patient population

The Commission on Cancer: Reengineering the National Cancer Data Base

The case against maintenance rituximab in Follicular lymphoma. Jonathan W. Friedberg M.D., M.M.Sc.

Open questions in the treatment of Follicular Lymphoma. Prof. Michele Ghielmini Head Medical Oncology Dept Oncology Institute of Southern Switzerland

PROGRAM OVERVIEW. Copyright 2018 American Society of Clinical Oncology. All rights reserved.

Using the NIH Collaboratory's and PCORnet's distributed data networks for clinical trials and observational research - A preview

GENERAL PRACTITIONERS IN THE 1ST LINE OF CANCER PREVENTION

European Cancer Network Aims and Activities

Recommendations on Screening for Colorectal Cancer 2016

CONSIDERATIONS IN DEVELOPMENT OF PEMBROLIZUMAB IN MSI-H CANCERS

National Horizon Scanning Centre. Bevacizumab (Avastin) for glioblastoma multiforme - relapsed. August 2008

A Population-Based Study on the Uptake and Utilization of Stereotactic Radiosurgery (SRS) for Brain Metastasis in Nova Scotia

The Accessible Information Standard - guidance for practices

Agenda. Illinois Diabetes Action Plan: What s In It for You? 10/27/2017

The New CP 3 R Application And Revisions To Standard 4.6 Integration Of The NCDB With The Accreditation Process

How sarcoma/gist research & expert care are organized in Italy

Standard Summary Project Fiche IPA centralised programmes

Development of a computerized tool for self-assessment of subjective symptoms that can be integrated in a Personal health record

Landscape of Cancer Registration in South Africa

Emerging Issues in Cancer Prevention and Control

Hans Erik Henriksen, CEO Healthcare DENMARK

CDC s National Comprehensive Cancer Control Program (NCCCP): 2010 Priorities and New Program Opportunities

Transcription:

The Czech National Health Care Information System (NH-IS) and its strategy in building population-based reporting Evropská unie Evropský sociální fond Operační program Zaměstnanost Regional reporting of NH-IS

I. Introducing NH-IS Evropská unie Evropský sociální fond Operační program Zaměstnanost Regional reporting of NH-IS

The Czech National Health Care Information System NH - IS NH-IS can contribute to the optimization of health care system and to the monitoring of population of health. NH-IS = very complex system Statistical surveys (clinical reports on care, economy of providers) Health care registries (real world observations, based on representative reporting) Reference information systems (ehealth key components) International collaboration and reporting (Health Data OECD, Eurostat, EHIS, EHLEIS, )

Key mission of the Czech NH-IS I. Evidence-based medicine NH-IS! Clinically based evidence 14% 12% 10% 8% 6% 4% 2% 0% UL: 0,7 TP: 0,9 MO: 3,6 DC: 6,4 LI: 37,8 CL: 10,8 JN: 30,3 Počet (na 10 000 osob) CH: 28,9 SO: 24,7 TC: 5,4 DO: 4,0 KV: 8,1 CV: 0,9 LN: 3,5 LT: 4,1 ME: 3,8 MB: 7,6 KD: 5,4 RA: 5,3 PH: 11,1 NB: 3,3 AX: 12,6 PS: 12,5 BE: 1,0 PZ: 9,4 KO: 13,8 RO: 8,8 PM: 22,9 KH: 2,1 PJ: 12,9 PB: 4,2 BN: 2,5 SM: 24,2 JC: 12,9 HB: 2,8 TU: 12,8 HK: 52,3 PA: 21,7 CR: 11,2 NA: 8,4 RK: 13,0 UO: 9,7 SY: 8,3 SU: 1,1 JE: 1,9 BR: 0,8 OP: 6,2 OT: 12,8KA: 7,1 KT: 9,4 ST: 3,0 PT: 43,4 PI: 7,6 CB: 29,3 TA: 3,5 PE: 3,2 JH: 32,0 JI: 22,9 TR: 3,6 ZR: 2,1 BO: 3,7 BK: 1,0 BM: 3,9 PV: 3,2 VY: 0,9 OL: 0,8 KM: 2,4 PR: 2,8 ZL: 2,7 NJ: 25,7 VS: 14,8 FM: 36,3 CK: 13,1 ZN: 6,1 UH: 1,5 HO: 0,5 BV: 0,7 Everybody knows what to do! Does really everybody do it?

Key mission of the Czech NH-IS II. Basic elements of effective e-health information system Czech approach: 1 2 3 4 - e-identification/certification of health care professionals - e-identification/certification of health care providers - monitoring of patient s trajectory in the health care system - quantification of consumed health care services: classification, extent and cost National registry of health care professionals National registry of health care providers Health care records in centralized data store of reimbursement companies

II. Building NH-IS: main challenges Evropská unie Evropský sociální fond Operační program Zaměstnanost Regional reporting of NH-IS

Effective system must answer very complex questions How to facilitate and control implementation of clearly given evidence-based guidelines? and how to update them? Interventions How to control population based interventions in a way which supports equity of care? and how to interlink consequent steps? How to control population and its health status (mortality, morbidity, survival,.)?

Effective system must cover multiple and heterogeneous data sources DATA INTEGRATION and reporting? HOW TO MANAGE IT? SEPARATED KEY INFORMATION SOURCES Diagnostics NON-STANDARDIZED INFORMATION SYSTEMS Clinical monitoring Health care payers

Effective system cannot increase administrative burden of health care professionals? The Czech strategy is to develop a system utilizing already generated / collected administrative data and health care records

III. Three views defining modern NH-IS Evropská unie Evropský sociální fond Operační program Zaměstnanost Regional reporting of NH-IS

I. Management view Integration of very complex data Cost Optimization of networks; reasonable distribution of care Outcomes Processes Therapy Health technology assessment; cost effectiveness Inpus Diagnostics Risks QA/QC: Health care quality assessment

II. System view Comprehensive coverage of all segments of care Diagnostics & therapy Prevention screening Primary care Follow-up Supportive care Palliative care Really comprehensive national health care data collection cannot be based on hundreds of separated registries for individual diagnoses

III. Legal background including data integration and protection policy Ensuring representative data is a significant step to guarantee the system functionality; this also includes the legislation.! This applies particularly to the Amendment to Act No. 372/2011 Coll., on Health Services, which would make it possible to analyse data from health care payers.!!

Conclusion: NH-IS architecture National registry of health care professionals Targeted surveys National registry of health care providers Specialized registries Health care records in centralized data store of reimbursement companies

Example of outcomes: The Czech National Cancer Care Information System Czech National Cancer Control Program Information Platform

IT infrastructure for monitoring of cancer care Cancer centres network as a regional managing system Epidemiology Population-based registries Population and treatment burden National Cancer Registry Hospitals Specialized registries Hospital information systems Local and national registries Monitoring of health care EHR Primary care (GPs, gynaecologists) Hospital care Specialized care and cancer centres Equity of health care Structure of health care Results of health care Quality of health care REPORTS Distribution of health care Volume of health care Data validation

Examples of IS functionality: Hospital-based monitoring Self benchmarking against centralized repository Dissemination of reports among centers CENTRALIZED DWS Representative base for clinically relevant analyses of consecutively treated patients

Set of indicators: health care quality & population-based health indicators

EXAMPLE OF RESULTS - I. Modern comprehensive data-based reporting www.svod.cz Czech National Cancer Control Program Information Platform

National on-line data-based reporting www.svod.cz www.kolorektum.cz www.rektum.cz www.mefanet.cz

Treated patients / year Counts per 100 000 inhabitants Counts per 100 000 inhabitants Examples of reporting: I. Population level & II. Hospital level Model diagnosis: colorectal carcinoma Main trends: incidence & mortality 600 Main trends: prevalence +49.1% Clinical stages: primary diagnosis 100% TNM 2. TNM 3. TNM 4. TNM 5. TNM 6. TNM 7. 500 80% 400 300 60% 200 40% incidence mortality Incidence Mortality Absolute counts in 2013 8 066 3 716 Counts per 100 000 in 2013 76.7 35.4 100 0 1990 1992 1994 %: trend change 2003 2013 1996 1998 2000 2002 2004 2006 2008 2010 2012 Prevalence (31/12/2013) Absolute counts 54 982 Counts per 100 000 523,1 20% 0% 1977 1979 1981 1983 1985 1987 1989 1991 1993 1995 1997 1999 Stage of the disease 2001 2003 2005 2007 2009 2011 2013 1 2 3 4 unknown not recorded Distribution of care among regions/centers 600 500 400 300 Volume of cancer care: capacity mapping 2006-2014 N = 54 360 Benchmarking of outcome measures: Survival after given medication vs. EBM trials 1,0 0,8 0,6 Medián OS Registr CORECT medián OS - 28,4 měsíce Studie AVF2107g* medián OS - 20,3 měsíce Studie NO16966 * medián OS - 21,2 měsíce 200 0,4 100 0,2 0 1 6 11 16 21 26 31 36 41 46 51 Rank of hospitals 0,0 0 12 24 36 48 60 72 84 96 Čas (měsíce)

Examples of reporting: III. Predictive mapping of cancer burden Model diagnosis: colorectal carcinoma CRC (C18 C20) Stage I Stage II Stage III Stage IV TOTAL INCIDENCE PREVALENCE (95 % CI) (95 % CI) ---------- Prediction: 2016 ---------- 2050 21 376 (1903; 2197) (21 136; 21 616) 1951 (1844; 2057) 2117 (2010; 2226) 1631 (1359; 1903) 8037 (7298; 8777) 19 104 (18 877; 19 331) 15 114 (14 912; 15 316) 7083 (6945; 7221) 65 331 (64 911; 65 751)

Predictive mapping of cancer burden model concept Population-based predictive models Expert inputs and corrections Adjusted for clinical stage Stagespecific estimate of prevalence of treated patients Surviving cancer patients with relapse/progression of primary disease Primarily treated patients Relapse/ progression Scenario 1 (%) Scenario (%) Scenario (%) Scenario (%) Cost calculation

Example of clinical outcome assessment Model diagnosis: colorectal carcinoma Population-based monitoring CRC: 5-yr relative survival Cohort 1990 1994 Cohort 1995 1999 Period 2005 2009 Period 2010 2014 Hospital-based benchmarking Stage 1 64,9 % 76,2 % 87,6 % 91,8 % Stage 2 48,4 % 62,9 % 73,7 % 79,4 % Stage 3 40,0 % 41,8 % 54,5 % 62,2 % Stage 4 12,0 % 10,7 % 13,9 % 16,2 % Total 47,9 % 51,7 % 59,4 % 65,4 %

EXAMPLE OF RESULTS - II. Data-driven cancer screening - population based design - Czech National Cancer Control Program Information Platform

Examples of IS functionality: Management of population-based screening Selection of people to be addressed Prospective mode Backward monitoring Czech PB screening: system of birthday invitation driven by health care payers. Retrospective mode

Example of reports on the Czech PB colorectal cancer screening program CRC screening: FOBT regional coverage CRC screening: age-specific coverage FOBT positivity: time trend and regional profile Men and women aged over 50 Coverage in percents Coverage by screening Men and women aged over 50 Positivity 10% SO: 31,8 KV: 32,2 CH: 24,0 TC: 25,0 DO: 31,1 PJ: 33,0 KT: 26,6 UL: 28,5 LI: 34,7 TP: 32,9 MO: 35,0 CL: 32,4 JN: 27,4 CV: 38,6 LN: 32,6 PT: 22,0 PB: 31,1 PI: 35,7 ST: 21,8 CK: 30,3 LT: 37,4 KD: 29,5 RA: 22,7 CB: 30,2 DC: 26,6 AX: 23,9 PS: 30,0 PZ: 23,4 BE: 27,7 RO: 36,0 PM: 25,5 MB: 36,7 ME: 26,9 PH: 26,6 BN: 23,4 TA: 31,6 PE: 33,4 JH: 30,1 NB: 33,1 KO: 25,6 KH: 24,4 SM: 23,4 JC: 25,8 HB: 30,4 JI: 33,6 TU: 29,8 HK: 26,9 PA: 30,5 CR: 33,7 TR: 40,1 ZR: 29,6 ZN: 34,3 NA: 36,9 RK: 36,5 UO: 37,5 SY: 33,1 BO: 29,5 BK: 36,0 BM: 30,0 BV: 31,9 SU: 43,4 PV: 37,9 VY: 29,7 HO: 35,0 JE: 35,1 OL: 39,8 BR: 33,8 PR: 40,5 KM: 37,4 ZL: 37,8 UH: 39,1 OP: 34,6 OT: 31,5KA: 31,3 NJ: 27,2 VS: 33,8 FM: 25,5 < 25,0 25,0-30,0 30,0-35,0 35,0-40,0 > 40,0 50% 40% 30% 20% 10% 0% One-year interval Two-year interval Muži Ženy 50-54 55-59 60-64 65-69 70-74 75-79 80-84 85+ 8% 6% 4% 2% 0% 2006 2007 2008 2009 2010 2011 2012 2013 2014 14% Positivity 12% 10% 8% 6% CR 7,2% Range in regions 5,9-8,6% Year 4% 30,8% 21,8% 43,4% Age group 2% 0% Region Coverage in time trend: 2013 vs. 2014 Share of primary care specialists Primary screening Colonoscopy regional coverage Men and women aged over 50 DC: 4,3 UL: 4,7 LI: 5,4 TP: 2,6 MO: 2,7 CL: 4,1 JN: 4,6 Difference (%) < 3,0 3,0-4,0 Women aged over 50 Year 2011, N = 310 393 examinations 151 (0,1%) other/unknown expertise Year 2012, N = 325 631 examinations 77 (0,02%) other/unknown expertise Men and women aged over 50 UL: 9,0 TP: 1,7 MO: 7,8 DC: 7,5 CL: 21,3 LI: 69,9 JN: 33,8 Number per 10,000 < 10,0 10,0-20,0 CV: 2,0 LT: 4,5 SM: 5,8 TU: 4,2 SO: 2,2 KV: 3,7 LN: 4,6 ME: 5,2 MB: 5,3 JC: 6,3 NA: 2,5 CH: 3,9 KD: 5,8 RA: 5,2 PH: 4,5 NB: 4,9 HK: 4,3 AX: 4,5 RK: 4,4 PS: 4,6 TC: 5,2 BE: 3,7 PZ: 4,8 KO: 4,0 PA: 3,5 RO: 5,0 PM: 2,2 UO: 4,2 KH: 4,5 CR: 3,8 PJ: 3,4 PB: 6,0 BN: 6,3 DO: 2,5 HB: 6,5 SY: 7,2 JE: 6,3 SU: 3,9 BR: 3,7 OP: 4,7 OT: 3,9KA: 4,2 4,0-5,0 5,0-6,0 > 6,0 86,6% 13,3% 86,4% 13,6% SO: 35,8 KV: 16,4 CH: 46,4 TC: 12,0 DO: 13,4 CV: 0,9 PS: 13,8 PJ: 22,7 LN: 20,6 RA: 8,5 RO: 8,6 PM: 25,5 PB: 21,0 LT: 22,4 BE: 2,5 PZ: 26,2 ME: 16,0 KD: 12,3 PH: 27,7 AX: 33,4 BN: 8,4 MB: 27,9 NB: 13,1 KO: 41,5 KH: 11,0 SM: 28,8 JC: 14,2 HB: 8,1 TU: 18,6 HK: 86,9 PA: 49,4 CR: 26,5 NA: 13,2 RK: 40,8 UO: 14,6 SY: 15,2 SU: 6,5 JE: 43,8 BR: 1,9 OP: 10,5 OT: 24,3KA: 19,5 20,0-30,0 30,0-40,0 > 40,0 PI: 2,3 OL: 4,2 KT: 3,4 TA: 4,1 PE: 4,2 ZR: 5,8 NJ: 3,2 FM: 4,2 ST: 4,5 BK: 3,9 PV: 7,3 PR: 4,9 JI: 3,4 BO: 4,5 JH: 3,0 VS: 4,2 PT: 2,3 TR: 5,0 BM: 4,1 VY: 4,8 KM: 4,9 CB: 4,7 ZL: 3,8 Year 2013, N = 339 424 examinations 88 (0,03%) other/unknown expertise Year 2014, N = 423 660 examinations 74 (0,02%) other/unknown expertise KT: 37,5 ST: 37,3 PT: 103,3 PI: 9,2 CB: 26,0 TA: 9,3 PE: 26,1 JH: 55,7 JI: 36,0 TR: 37,8 ZR: 26,3 BO: 10,1 BK: 2,2 BM: 10,1 PV: 4,8 VY: 1,5 OL: 3,3 KM: 3,1 PR: 9,4 ZL: 17,4 NJ: 35,2 VS: 20,6 FM: 65,7 CK: 4,2 ZN: 3,3 BV: 5,8 HO: 6,4 UH: 6,6 CK: 12,7 ZN: 21,5 BV: 2,8 HO: 1,7 UH: 15,1 +4,4% +2,0% +7,3% 86,7% 13,3% Practitioner 88,8% 11,2% Gynecologist 23,2 0,9 103,3

PB CRC screening: improvement 2010 -> Colorectal cancer epidemiology Colorectal cancer screening

EXAMPLE OF RESULTS - III. Data-driven changes in cancer care management www.onconet.cz Czech National Cancer Control Program Information Platform

www.onconet.cz Diagrams of cancer care available for each region PDF download Regional models of cancer care, presenting professionals and navigating patients Interactive maps Access points www.onconet.cz

Regional models of cancer care Comprehensive cancer care Map of facilities involved in comprehensive cancer care Types and numbers of facilities Diagram of cancer care Link to a regional Cancer Centre Regional news www.onconet.cz Detail of a health care facility

Cancer Centres On-line Comprehensive cancer care Equipment characteristics Clinical research Performance www.onconet.cz and more

Target area of CCCN Together, South Moravian Region and the Vysočina Region (target area for CCCN) account for 18% of the total area of the Czech Republic. Although these two regions are geographically next to each other, their remote parts are very different and provide thus representative sample for piloting of CCCN. South Moravian Region Vysočina Region Both regions Population (as of 31/12/2015) 1 175 025 509 475 1 684 500 Area (km2) 7 195 6 796 13 991 Population density (per km2) 163 75 120 Number of districts 7 5 12 Number of municipalities 673 704 1 377 Total length of roads and motorways (km, estimation) 4 500 5 000 9 500 Total length of railway network (km, estimation) 800 650 1 450

Pilot CCCN: South Moravian Region and Vysocina Region cancer care infrastructure Type of health care facility www.onconet.cz CCCN Comprehensive Cancer Centre [n=1] Cancer Centres [n=3] Children s cancer centres [n=1] Haemato-oncology centres [n=1] Constituent parts of CCCN [n=4] HCF cooperating with CCs [n=20] Mammography screening centres [n=13] Colonoscopy screening centres [n=29] LCTHs and hospices [n=20] All [n=92]

Conclusion and Current Challenges Evropská unie Evropský sociální fond Operační program Zaměstnanost Regional reporting of NH-IS

Personalized medicine needs personalized data collection and reporting Hospital IS (EHR) Individualized tracking of patient flow = future of cancer care control. Thank you very much for your attention